# OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
> **ANDA217398** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2025-09-26
## Drug
- **FDA Application Number:** ANDA217398
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- **Generic name:** OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2025-09-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217398)
---
*AI Analytics · CC0 1.0*